Efficacy and safety of injection Botulinum toxin in canalicular obstruction due to trauma
- PMID: 37719907
- PMCID: PMC10499646
- DOI: 10.1016/j.mjafi.2021.09.007
Efficacy and safety of injection Botulinum toxin in canalicular obstruction due to trauma
Abstract
Background: The treatment of epiphora has undergone tremendous change in the past, and minimally invasive techniques are being preferred over traditional surgical options. One of them is the use of Inj Botulinum toxin, but there are very few studies that have explored its role in treating post-traumatic epiphora. This study was undertaken to find out the safety and efficacy of injection Botulinum toxin in treating epiphora due to canalicular obstruction following trauma.
Methods: A longitudinal interventional study was done, and a total of 50 patients were recruited. All patients were subjected to Inj Botulinum toxin in the lacrimal gland (10 units). The study was done for a period of 6 months, and patients were followed up for a period of another 6 months. Changes in Munk score, Schirmer test, and tear meniscus height were considered the main outcome measures.
Results: In our study, there were 38 males and 12 females. The age of the patients varied from 24 yrs to 67 yrs. Inj Botulinum toxin was found to be effective in 80% (n = 40/50) of cases as they reported a reduction in watering from eyes after administration of this injection. The complication associated with this treatment was minimal in our study as four patients reported diplopia, whereas two patients developed Ptosis that resolved spontaneously within two months.
Conclusion: Inj Botulinum toxin was found to be effective in epiphora caused by canalicular obstruction due to trauma. This treatment should be considered as an alternative treatment modality as it often leads to satisfactory reduction in epiphora in patients with less complications compared to surgical intervention.
Keywords: Botulinum toxin; Canalicular obstruction; Epiphora.
© 2021 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.
Conflict of interest statement
The authors have none to declare.
Figures




Similar articles
-
Comparison of the efficacy and safety of lacrimal gland botulinum toxin injection in functional versus non-functional epiphora.Cutan Ocul Toxicol. 2024 Dec;43(4):278-286. doi: 10.1080/15569527.2024.2402402. Epub 2024 Sep 17. Cutan Ocul Toxicol. 2024. PMID: 39287173
-
Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora.Oman J Ophthalmol. 2019 May-Aug;12(2):104-107. doi: 10.4103/ojo.OJO_52_2018. Oman J Ophthalmol. 2019. PMID: 31198296 Free PMC article.
-
Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.Eye (Lond). 2016 Aug;30(8):1056-62. doi: 10.1038/eye.2016.88. Epub 2016 May 20. Eye (Lond). 2016. PMID: 27197871 Free PMC article.
-
Lacrimal gland botulinum toxin injection for epiphora management.Orbit. 2022 Apr;41(2):150-161. doi: 10.1080/01676830.2021.1966810. Epub 2021 Aug 15. Orbit. 2022. PMID: 34396904 Free PMC article. Review.
-
A review on use of botulinum toxin for intractable lacrimal drainage disorders.Int Ophthalmol. 2018 Oct;38(5):2233-2238. doi: 10.1007/s10792-017-0661-9. Epub 2017 Aug 1. Int Ophthalmol. 2018. PMID: 28766277 Review.
Cited by
-
Surgical outcomes of external dacryocystorhinostomy with flap versus without flap in acquired nasolacrimal duct obstruction.Indian J Ophthalmol. 2024 Nov 1;72(11):1670-1672. doi: 10.4103/IJO.IJO_3379_23. Epub 2024 Oct 26. Indian J Ophthalmol. 2024. PMID: 39462928 Free PMC article. No abstract available.
-
Efficacy and safety of botulinum toxin as a non-surgical option for upper eyelid retraction in active thyroid-associated ophthalmopathy: a prospective interventional study.Int Ophthalmol. 2025 Jul 15;45(1):293. doi: 10.1007/s10792-025-03658-4. Int Ophthalmol. 2025. PMID: 40663254
References
-
- Sekhar G.C., Dortzbach R.K., Gonnering R.S., Lemke B.N. Problems associated with conjunctivodacryocystorhinostomy. Am J Ophthalmol. 1991;112:502–506. - PubMed
-
- Rosen N., Ashkenazi I., Rosner M. Patient dissatisfaction after functionally successful conjunctivodacryocystorhinostomy with Jones tube. Am J Ophthalmol. 1994;117:636–642. - PubMed
-
- Steele E.A., Dailey R.A. Conjunctivodacryorhinostomy with the frosted Jones pyrex tube. Ophthalmic Plast Reconstr Surg. 2009;25:42–43. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous